NSE live Recos 19.02.2021

Wabag Tgt 288 After 300 breakout Tgt 450

Repco  next 1 week Tgt 440, next 1 month Tgt 550

Kalpataru power next 1 week Tgt 425

NIACL week Tgt 150  achieved today - 2.20 pm

NSE Recos 18.02.2021

Tata Chem may breakout above 587 and rally uotp620. May dip to 555. Key support level 540

PTC Tgt 120

Voltas Tgt 1100

Tatamotors new Tgt 389. Fundamentally not strong. May fall any time. Be cautious

Orientcem Tgt 110

Greaves cotton Tgt 125

KVB Tgt 72

Multibagger: Neogen chemicals, Lupin, Kajariacer 

News: 

Granules got approval for pottasium chloride ER capsules USP

Greaves cotton's arm to setup manufacturing plant in TN

KEC international secures new order of Rs.1680 Cr

17.02.2021 Multibagger

Last chance before start to blast.

Buy at every dip for long term :

Sequent, Goldiam, Apar Industries, Tataconsumer, Syngene 

Mothersonsumi Tgt1 225 achieved

16.02.2021 Stock Recos

NIACL - Now sideways- week tgt 150 - month tgt 200

ORIENTCEM - Tgt1 110 - Tgt2 125

MOTHERSUMI - Tgt1 225 - Tgt2 275 within March

SUVENPHAR - Tgt1 575 after some correction

NCC - New Tgt 110

Hindalco - New Tgt 325

16.02.2021 Tracking

Goldiam Tgt 350 achieved

Hindalco Tgt 300 acheived

ACC Tgt 1825 achieved

Tata consu nearing Tgt 650. Book partial profit around 630

15.02.2021 BTST Recos

Apar Indust Tgt: 650

Goldiam : Tgt 350

Container corp acheived Tgt1 548 today posted on 10.2.2021

Laurus lab acheived Tgt1 340 today posted on 10.2.2021

10-02-2021 Stock Recos

Laurus lab : May  tocuh 340 today correction follows for one week

Titan : could  touch 1600 BTST UPtrend extends for another 10 days

Eicher motors : may reach further 75 points today atleast

Gujarat Gas : uptrend continues Tgt1 520 

Hindalco : Intraday Tgt1 300

ACC : moves in sidewasy today BTST 1825

Container Corp : two weeks Tgt1 650  Intraday 548

Tata consumer : A goldan mine, after 20 point corrction immediate Tgt 650

07-02-2021 Stock bulls turn to earnings after Budget-sparked rally - Suggestions for 08-02-2021

Having propelled the benchmark gauge almost 10% this week in a budget-driven rally, stock bulls in India are now counting on earnings to be the catalyst for the next leg up. 

The 34 NSE Nifty 50 Index members that have declared December-quarter results have posted a 34% jump in earnings from a year earlier, according to a note from local brokerage Kotak Securities Ltd. on Friday. With India’s daily new Covid-19 infections slowing and the vaccination drive gaining pace, analysts are betting on a stronger rebound in the economy and corporate profits in the months ahead.
“Everything is in place - macro, policy, global backdrop,” said Gautam Duggad, head of research at Motilal Oswal Financial Services Ltd. “The market now just needs one thing to keep rallying -- earnings.”
Rising optimism over earnings comes after the government unveiled a $500 billion spending plan in its budget on Feb. 1. That saw the benchmark Nifty 50 Index surge the most since April this week. The Reserve Bank of India raised its forecasts for economic growth on Friday, while assuring markets of ample liquidity to manage the government’s massive borrowing.

Short Term Buy:

Canara Bank | LTP: Rs 162 | Target price: 203 | Stop loss: Rs 130 | Upside: 25%

The key support levels are Rs 140 and Rs 130. One can buy the stock at the current levels for the target of Rs 185, followed by Rs 203.

Pharma stocks have been among the top gainers, along with technology stocks, in the wake of the COVID-19 pandemic.

The sector was in focus in Union Budget 2021, with Finance Minister announcing an outlay of Rs 2,23,846 crore for health and well being.This was an increase of 137 percent compared to 2020 when the allocation stood at Rs 94,452 crore. The rise was primarily led by Rs 35,000 crore for COVID-19 vaccines. The finance minister also announced a new scheme called the PM Atmanirbhar Swasth Bharat Yojana for boosting primary, secondary, and tertiary healthcare, with a budgetary outlay of Rs 64,180 crore spread over six years. This funding would be used to develop capacities of the healthcare system, institutions for detection and cure of new and emerging diseases.

Buy:   

Granules India : Buy above 360 for Tgt of 440 Currently in correction mode. Buy at dips for medium term upside 50%

Laurus Labs : Small correction may happen upto 315 Buy around 320 Tgt 450 for short term Upside 35% may expect